Johnson & Johnson is teaming up with AdoRx Therapeutics to develop lung cancer drugs. The deal gives J&J an exclusive option to research, develop and commercialize AdoRx antagonists. AdoRx ...

AdoRx Therapeutics, a UK based drug discovery company focused on the identification of new cancer therapeutics, today announced that it has closed an initial $10 million investment round financed by ...

DUBLIN – Scottish startup Adorx Therapeutics Ltd. is the latest contender to tackle the knotty problem of immunosuppression in the tumor microenvironment through adenosine receptor inhibition. The ...